Perth-based burns treatment company Clinical Cell Culture Ltd has entered into a supply agreement with pharmaceutical company CSL Ltd for the supply of Trypsin, a key component of the Company's ReCell tissue harvesting device.

Perth-based burns treatment company Clinical Cell Culture Ltd has entered into a supply agreement with pharmaceutical company CSL Ltd for the supply of Trypsin, a key component of the Company's ReCell tissue harvesting device.